1. Home
  2. REZI vs WGS Comparison

REZI vs WGS Comparison

Compare REZI & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Resideo Technologies Inc.

REZI

Resideo Technologies Inc.

N/A

Current Price

$18.65

Market Cap

2.7B

Sector

Industrials

ML Signal

N/A

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

N/A

Current Price

$69.54

Market Cap

2.7B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
REZI
WGS
Founded
2018
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Retail: Computer Software & Peripheral Equipment
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.7B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
REZI
WGS
Price
$18.65
$69.54
Analyst Decision
Buy
Strong Buy
Analyst Count
6
8
Target Price
$29.83
★ $93.50
AVG Volume (30 Days)
★ 1.7M
722.5K
Earning Date
11-10-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 62.37
EPS
★ 0.68
N/A
Revenue
★ $7,472,000,000.00
$427,539,000.00
Revenue This Year
N/A
$12.70
Revenue Next Year
N/A
$24.31
P/E Ratio
$27.65
★ N/A
Revenue Growth
10.52
★ 39.97
52 Week Low
$15.90
$32.21
52 Week High
$43.04
$170.87

Technical Indicators

Market Signals
Indicator
REZI
WGS
Relative Strength Index (RSI) 57.71 48.91
Support Level $15.90 $68.55
Resistance Level $19.00 $73.04
Average True Range (ATR) 0.61 5.62
MACD 0.34 0.96
Stochastic Oscillator 90.60 81.47

Price Performance

Historical Comparison
REZI
WGS

About REZI Resideo Technologies Inc.

Resideo Technologies Inc manufactures, develops, and distributes sensing and control products and solutions for residential and commercial markets. Its product portfolio includes heating, ventilation, and air conditioning (HVAC) controls, smoke and carbon monoxide detection products, fire suppression products, and security products. Its products and solutions are used in residential and commercial buildings across various countries.

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: